N. Padullés

Methylprednisolone Pulses Plus Tacrolimus in Addition to Standard of Care vs. Standard of Care Alone in Patients With Severe COVID-19. A Randomized Controlled Trial

C. Tebé, S. Videla, J. Niubó, 2021, Frontiers in Medicine.

PREDICTORS OF INFLIXIMAB TROUGH CONCENTRATIONS IN INFLAMMATORY BOWEL DISEASE PATIENTS USING A REPEATED MEASURES DESIGN.

H. Colom, F. Rodríguez-Moranta, J. Guardiola, 2020, Therapeutic drug monitoring.

Pragmatic, open-label, single-center, randomized, phase II clinical trial to evaluate the efficacy and safety of methylprednisolone pulses and tacrolimus in patients with severe pneumonia secondary to COVID-19: The TACROVID trial protocol

C. Tebé, S. Videla, J. Niubó, 2021, Contemporary Clinical Trials Communications.

External Evaluation of Population Pharmacokinetic Models of Infliximab in Patients With Inflammatory Bowel Disease

H. Colom, J. Guardiola, A. Padullés, 2017, Therapeutic drug monitoring.

Beneficial effect of corticosteroids in preventing mortality in patients receiving tocilizumab to treat severe COVID-19 illness

M. Gasa, A. Ariza-Solé, J. Sabater, 2020, International Journal of Infectious Diseases.